Inventor · disambiguated record
Godfrey Jonah Anderson Rainey
Also filed as: RAINEY GODFREY · RAINEY GODFREY JONAH · RAINEY GODFREY JONAH ANDERSON
18 granted patents·14 pending applications·113 citations·filing 2008–2025
93Inventor score
Top patents by PatentIndex Score
32 records- 0195US10442854B2Neutralizing anti-influenza binding molecules and uses thereofMEDIMMUNE LLC·Filed 2016·Granted Oct 15, 2019·13 cites·11 claims
- 0293US10457732B2Bispecific binding proteins and uses thereofMEDIMMUNE LLC·Filed 2017·Granted Oct 29, 2019·10 cites·12 claims
- 0393US9096877B2Fc region-containing polypeptides that exhibit improved effector function due to alterations of the extent of fucosylation, and methods for their useJOHNSON LESLIE S·Filed 2010·Granted Aug 4, 2015·47 cites·16 claims
- 0492US10744204B2Conjugated compounds comprising cysteine-engineered antibodiesMEDIMMUNE LLC·Filed 2015·Granted Aug 18, 2020·8 cites·15 claims
- 0591US9889197B2Covalently-associated diabody complexes that possess charged coil domains and that are capable of enhanced binding to serum albuminJOHNSON LESLIE S·Filed 2011·Granted Feb 13, 2018·13 cites·12 claims
- 0690US11203633B2Polynucleotides encoding antibodies or antigen binding fragments thereof that bind pseudomonas pervMEDIMMUNE LTD·Filed 2020·Granted Dec 21, 2021·2 cites·25 claims
- 0789USRE49908EBispecific binding proteins and uses thereofMEDIMMUNE LLC·Filed 2021·Granted Apr 9, 2024·1 cites·43 claims
- 0889US11279759B2Bispecific binding proteins and uses thereofMEDIMMUNE LLC·Filed 2019·Granted Mar 22, 2022·4 cites·19 claims
- 0989US10882897B2Neutralizing anti-influenza binding molecules and uses thereofMEDIMMUNE LLC·Filed 2019·Granted Jan 5, 2021·3 cites·14 claims
- 1087US2025074986A1Bispecific binding proteins and uses thereofMEDIMMUNE LLC·Filed 2024·Application pending·0 cites
- 1184US10160812B2Bispecific HER2 antibodiesMEDIMMUNE LLC·Filed 2015·Granted Dec 25, 2018·4 cites·18 claims
- 1282US11926657B2Neutralizing anti-influenza binding molecules and uses thereofMEDIMMUNE LLC·Filed 2022·Granted Mar 12, 2024·0 cites·13 claims
- 1382US7998487B2Antitoxin and vaccine platform based on nodavirus VLPsSALK INST FOR BIOLOGICAL STUDI·Filed 2008·Granted Aug 16, 2011·4 cites·8 claims
- 1481US10597439B2Combination therapies using anti-pseudomonas PSL and PCRV binding moleculesMEDIMMUNE LLC·Filed 2012·Granted Mar 24, 2020·4 cites·7 claims
- 1577US12428473B2Combination therapies using anti-pseudomonas PSL and PCRV binding moleculesMEDIMMUNE LTD·Filed 2021·Granted Sep 30, 2025·0 cites·20 claims
- 1675US2022251204A1Bispecific binding proteins and uses thereofMEDIMMUNE LLC·Filed 2021·Application pending·0 cites
- 1773US2024000933A1Human antibodies to tn antigenBOEHRINGER INGELHEIM INT·Filed 2023·Application pending·0 cites
- 1872US2025243262A1Combination therapies using anti-pseudomonas psl and pcrv binding moleculesMEDIMMUNE LTD·Filed 2025·Application pending·0 cites
- 1971US11524993B2Neutralizing anti-influenza binding molecules and uses thereofMEDIMMUNE LLC·Filed 2020·Granted Dec 13, 2022·0 cites·14 claims
- 2069US2025353914A1Antigen-binding proteins and related methods of useGRITSTONE BIO INC·Filed 2025·Application pending·0 cites
- 2167US11707522B2Human antibodies to Tn antigenBOEHRINGER INGELHEIM INT·Filed 2018·Granted Jul 25, 2023·0 cites·15 claims
- 2265US2023295305A1Antigen-binding proteins and related methods of useGRITSTONE BIO INC·Filed 2023·Application pending·0 cites
- 2361US2023287128A1Antigen-binding proteins targeting kklc-1 shared antigenGRITSTONE BIO INC·Filed 2022·Application pending·0 cites
- 2460US2021069341A1Conjugated compounds comprising cysteine-engineered antibodiesMEDIMMUNE LLC·Filed 2020·Application pending·0 cites
- 2556US2024059797A1Engineered multi-specific antibodies and related methods of use and manufactureGRITSTONE BIO INC·Filed 2021·Application pending·0 cites
- 2648US2022213196A1Antigen-binding proteins targeting shared antigensGRITSTONE BIO INC·Filed 2019·Application pending·0 cites
- 2746US8404247B2Antitoxin and vaccine platform based on nodavirus VLPSYOUNG JOHN·Filed 2011·Granted Mar 26, 2013·0 cites·11 claims
- 2845US11718673B2Bispecific binding molecules that target the tumor microenvironment and an immune checkpoint proteinIMMETAS THERAPEUTICS INC·Filed 2020·Granted Aug 8, 2023·0 cites·8 claims
- 2944US2019241659A1Bispecific fusion polypeptides and methods of use thereofMEDIMMUNE LLC·Filed 2018·Application pending·0 cites
- 3042US2022162320A1Multispecific binding proteinsGRITSTONE BIO INC·Filed 2020·Application pending·0 cites
- 3138US2018085458A1Methods for treating clostridium difficile infection and associated diseaseMEDIMMUNE LLC·Filed 2016·Application pending·0 cites
- 3236US2017183397A1Multi-specific anti-pseudomonas psl and pcrv binding molecules and uses thereofMEDIMMUNE LLC·Filed 2015·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Godfrey Jonah Anderson Rainey files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →